Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Source:http://linkedlifedata.com/resource/pubmed/id/18250414

J. Immunol. 2008 Feb 15 180 4 2089-98

Download in:

View as

General Info

PMID
18250414